Cartesian Therapeutics, Inc.RNACNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank91
3Y CAGR+9.7%
5Y CAGR+10.7%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+9.7%/yr
vs +8.4%/yr prior
5Y CAGR
+10.7%/yr
Consistent
Acceleration
+1.2pp
Accelerating
Percentile
P91
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$31.47M+4.5%
2024$30.13M-25.5%
2023$40.45M+69.5%
2022$23.86M+14.0%
2021$20.94M+10.7%
2020$18.91M+15.4%
2019$16.39M-5.1%
2018$17.26M-4.5%
2017$18.08M+47.6%
2016$12.25M-